10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,147 | -26.1% | 149 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,321 | +0.1% | 149 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,313 | -1.2% | 149 | -35.5% | 0.00% | 0.0% |
| Q4 2022 | $8,418 | +180.6% | 231 | +102.6% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 114 | +137.5% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 48 | -51.5% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -46.7% | 99 | +1.0% | 0.00% | -50.0% |
| Q4 2021 | $15,000 | +66.7% | 98 | +58.1% | 0.00% | +100.0% |
| Q3 2021 | $9,000 | -18.2% | 62 | +6.9% | 0.00% | -50.0% |
| Q2 2021 | $11,000 | -38.9% | 58 | -42.6% | 0.00% | -33.3% |
| Q1 2021 | $18,000 | +157.1% | 101 | +98.0% | 0.00% | +200.0% |
| Q4 2020 | $7,000 | -46.2% | 51 | -66.2% | 0.00% | -66.7% |
| Q2 2020 | $13,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |